Durvalumab vs Omeprazole

Durvalumab vs Omeprazole: Overview

This comparison examines the pharmacological differences between Durvalumab and Omeprazole.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Omeprazole: Proton pump inhibitor that irreversibly blocks H+/K+-ATPase.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Omeprazole — 0.5-1 hour.

Chemical Properties

Molecular Formula: Omeprazole — C17H19N3O3S.

Molecular Weight: Omeprazole — 345.4170 g/mol.

Type: Durvalumab — Antibody; Omeprazole — Small molecule.